Latest Breaking News On - University of cambridge milner therapeutics institute - Page 1 : comparemela.com

Search jobs ALSA Ventures Launches Promatix to Develop Next Generation Novel Oncology Therapeutics LONDON (BUSINESS WIRE) ALSA Ventures today announced the launch of Promatix Inc., a Delaware incorporated company, to develop novel therapeutics with the potential to transform the treatment of cancer. Promatix will use its multi-omic proprietary database, TxPro, to mine for novel, and validate existing, drug targets. “As we mark off the 20 th anniversary of drafting the human genome, it’s clear we’re still in the early innings of a revolution in molecular biology. Taking a multi-omic approach to novel drug discovery, aided by advances in AI technology, Promatix will take a highly focused, data driven approach, to hunt for novel targets in oncology indications of unmet need,” said Alek Safarian, Executive Chairman of Promatix.

Delaware
United-states
Cambridge
Cambridgeshire
United-kingdom
Manchester
London
City-of
Katie-sunnucks
Jasmin-fisher
Namshik-han
Robert-balfour